Acceleron Pharma (XLRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Sales | 39,752 | 4,344 | 39,339 | 4,208 | 27,666 |
| Gross Profit | 39,752 | 4,344 | 39,339 | 4,208 | 27,666 |
| Operating Expenses | 58,665 | 55,916 | 64,920 | 53,131 | 48,802 |
| Operating Income | -18,913 | -51,572 | -25,581 | -48,923 | -21,136 |
| Other Income | 466 | 648 | 2,003 | 3,520 | 3,230 |
| Pre-tax Income | -18,447 | -50,924 | -23,578 | -45,403 | -17,906 |
| Income Tax | 4 | 15 | -4 | -34 | -44 |
| Net Income Continuous | -18,451 | -50,939 | -23,574 | -45,369 | -17,862 |
| Net Income | $-18,451 | $-50,939 | $-23,574 | $-45,369 | $-17,862 |
| EPS Basic Total Ops | -0.34 | -0.95 | -0.44 | -0.86 | -0.34 |
| EPS Basic Continuous Ops | -0.34 | -0.95 | -0.44 | -0.86 | -0.34 |
| EPS Diluted Total Ops | -0.34 | -0.95 | -0.44 | -0.86 | -0.34 |
| EPS Diluted Continuous Ops | -0.34 | -0.95 | -0.44 | -0.86 | -0.34 |
| EPS Diluted Before Non-Recurring Items | -0.34 | -0.95 | -0.44 | N/A | N/A |
| EBITDA(a) | $-17,971 | $-50,576 | $-24,572 | $-47,933 | $-20,127 |